FindTrial
Sign In

Registry study for the surveillance of patients participating in prospective phase I,II or III studies including Ventricular Assist Tissue (VAT)

Registry study for the surveillance of patients participating in prospective phase I,II or III studies including Ventricular Assist Tissue (VAT) - Registry study for the surveillance of patients participating in prospective phase I,II or III studies including Ventricular Assist Tissue (VAT)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00027292
Enrollment
53
Registered
2023-01-31
Start date
2022-01-10
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I50

Interventions

Group 1: Patients participating in prospective phase I,II or III studies including Ventricular Assist Tissue (VAT)

Sponsors

Universitätsmedizin Göttingen
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Participation in VAT-trial

Exclusion criteria

Exclusion criteria: not applicable

Design outcomes

Primary

MeasureTime frame
Observation period until end of life: - Frequency of major adverse cardiac events (MACE; non-fatal myocardial infarction, non-fatal stroke, and cardiovascular death) - Hospitalization for worsening of heart failure - NYHA class - Ejection fraction (assessed by echocardiography or MRI) - Frequency and severity of arrhythmic events - Change of NTproBNP - Time to mechanical circulatory assist device or heart transplantation - All-cause mortality—

Countries

Germany

Contacts

Public ContactWolfram-Hubertus Zimmermann

Universitätsmedizin Göttingen

sekretariat.pharma@med.uni-goettingen.de+49 551 39 65781

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026